FLUENT Completes First Harvests at Rosa Facility, Advancing Its Growth Strategy and Proving Operational Execution

Rhea-AI Summary

FLUENT (OTCQB: CNTMF) completed the first harvests at Rosa, its new Florida indoor cultivation facility, on Nov. 4, 2025. Rosa increases FLUENT's premium indoor flower canopy by approximately 25% and produced a first harvest of 400 pounds of flower, with more than 70% comprising large and medium premium buds.

Product from Rosa will primarily supply the company's KNACK brand for premium whole flower and pre-rolls in Florida, supporting statewide production and operational scale-up.

Positive

• Canopy +25% increase in premium indoor flower capacity
• First harvest 400 pounds of flower
• >70% of yield in large and medium premium buds
• Rosa designated to supply KNACK premium whole flower and pre-rolls

Negative

• None.

11/04/2025 - 12:45 PM

TAMPA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced the successful completion of the first series of harvests at Rosa, the company’s newest Florida indoor cultivation facility.

The inaugural harvests represent another significant operational milestone as FLUENT continues to expand its premium production capacity and elevate the quality of its flower offerings in Florida. The newly operational facility, adjacent to FLUENT’S existing large-scale Tampa cultivation campus, will increase the company’s premium indoor flower canopy by approximately 25%.

Rosa’s debut harvests are expected to deliver strong results, with the first yielding 400 pounds of flower, more than 70% of which consists of large and medium premium buds, as the team continues to focus on optimizing future outcomes.

“We believe that our preliminary results at Rosa validate FLUENT’s ability to build and operationalize a step-change in our cannabis cultivation in Florida. This new high-tech indoor facility has refined environmental controls, standardized nutrient protocols and post-harvest analytics to monitor and optimize yield and quality in real time, with data-driven optimization. Rosa will play a critical role in supporting our growing demand for premium flower as well as margin expansion,” said Dave Vautrin, Interim CEO of FLUENT. “I commend our cultivation team for delivering above expectations, as first harvests in new facilities tend to be difficult.”

Product from Rosa cultivation facility will primarily support the Company’s KNACK brand, supplying premium whole flower and pre-rolls for the Florida market.

FLUENT believes that the addition of Rosa strengthens the Company’s statewide production network and reinforces its commitment to operational excellence, sustainable growth, and delivering consistent, high-quality cannabis experiences to patients across Florida.

About FLUENT Corp.

FLUENT, a national cannabis consumer packaged goods company and retailer, is dedicated to being one of the highest quality cannabis companies for the communities it serves. This is driven by FLUENT's unrelenting commitment to operational excellence in cultivation, production, distribution, and retail experience. FLUENT produces an assortment of cannabis products under a diverse portfolio of brands including MOODS, Knack, Wandr, Bag-O and Hyer Kind. FLUENT operates in Florida, New York, Pennsylvania, and Texas. Headquartered in Tampa, Florida, FLUENT employs 700 employees across 8 cultivation and manufacturing facilities, 37 active retail locations and a wholesale division which trades under ENTOURAGE servicing third party retailers in New York. For more information on the Company’s wholesale division ENTOURAGE, please visit https://entouragewholesale.com/.

FLUENT’s Common Shares trade on the Canadian Securities Exchange under the symbol “FNT.U” and on the OTCQB Venture Market under the symbol “CNTMF”. For more information about the Company, please visit www.getFLUENT.com.

Forward-Looking Information

Certain information in this news release may constitute “forward-looking information” within the meaning of applicable securities laws. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved” or similar expressions. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent the Company’s expectations, estimates, and projections regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control.

Investors are cautioned that forward-looking information is necessarily based on many opinions, assumptions, and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the Company’s ability to execute its go-forward strategy; stock market volatility; changes in the business activities, focus and plans of the Company and the timing associated therewith; the timing of any changes to federal laws in the U.S. to allow for the general cultivation, distribution, and possession of cannabis; regulatory and licensing risks; changes in cannabis industry growth and trends; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation, including the Company’s interpretation of such regulation; public opinion and perception of the cannabis industry; and the risk factors described in the public filings of the Company filed with Canadian securities regulators and available under the Company’s profile at www.sedarplus.ca.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

The Company, through several of its subsidiaries, is directly involved in the manufacture, possession, use, sale, and distribution of cannabis in the adult-use and medical cannabis marketplace in the United States. Local state laws where the Company operates permit such activities however, investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the United States Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute, or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable United States federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with adult-use and medical cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under United States federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. The enforcement of federal laws in the United States is a significant risk to the business of the Company and any proceedings brought against the Company thereunder may adversely affect operations and financial performance.

The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law. For further information visit: https://getFLUENT.com/ and https://investors.getFLUENT.com/.

Investor Relations Contact

investors@getFLUENT.com

Media Contact:

press@getFLUENT.com

Officer Contact:

Matt Mundy, Chief Legal Officer

(850) 972-8077

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/59728944-00f0-4eed-8700-0605e65d54a4

FAQ

What did FLUENT announce about the Rosa facility on Nov. 4, 2025?

FLUENT announced completion of Rosa's first harvests, adding ~25% premium indoor canopy and producing a 400 lb inaugural yield.

How much flower did Rosa produce in its inaugural harvest for CNTMF?

The first harvest yielded 400 pounds of flower.

What portion of Rosa's first harvest was premium buds according to FLUENT (CNTMF)?

More than 70% of the first harvest consisted of large and medium premium buds.

Which FLUENT brand will Rosa primarily supply in Florida?

Rosa's product will primarily support the KNACK brand for premium whole flower and pre-rolls.

How will Rosa impact FLUENT's production network and customers in Florida?

Rosa strengthens statewide production capacity and aims to support growing demand for premium flower and consistent supply for patients.